A dynamic vascular–inflammatory–fibrotic loop in systemic sclerosis: an integrative immuno-vascular framework

BackgroundSystemic sclerosis (SSc) is characterized by a complex and heterogeneous interplay between vascular dysfunction, immune activation, and progressive fibrosis. Despite advances in molecular characterization, therapeutic responses remain inconsistent and often transient, suggesting that disease persistence arises from dynamic interactions rather than isolated pathogenic pathways.ObjectiveTo propose a clinically grounded conceptual framework that integrates vascular, immune, and fibrotic processes into a dynamic loop model of SSc, derived from longitudinal clinical observations and contextualized within existing immunological and vascular literature.MethodsThis integrative framework is informed by long-term clinical follow-up, nailfold videocapillaroscopy patterns, immune biomarker profiling, and outcome analyses reported in SSc cohorts. Observations are organized into operational domains and translated into testable predictions reflecting shifts in pathway dominance over time.ResultsThe proposed model conceptualizes SSc as a self-sustaining dynamic loop in which vascular injury, immune signaling, and fibrotic remodeling interact non-linearly. Capillaroscopic patterns emerge as relatively stable structural readouts of disease phase, while immune and oxidative biomarkers reflect more dynamic functional states. This framework accounts for clinical heterogeneity, variable therapeutic responses, and the limited durability of single-target interventions.ConclusionsRather than representing a static disease entity, SSc can be understood as a dynamic system governed by shifting pathway dominance within a persistent loop architecture. This model provides a unifying structure for interpreting disease heterogeneity and supports the development of stage-adapted, combination therapeutic strategies.